Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| interneuron | 6 studies | 33% ± 23% | |
| glutamatergic neuron | 6 studies | 45% ± 28% | |
| endothelial cell | 5 studies | 27% ± 12% | |
| GABAergic neuron | 5 studies | 45% ± 20% | |
| astrocyte | 5 studies | 31% ± 10% | |
| neuron | 4 studies | 21% ± 7% | |
| oligodendrocyte precursor cell | 4 studies | 30% ± 8% | |
| epithelial cell | 3 studies | 18% ± 4% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 5 studies | 44% ± 16% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 100% | 4126.78 | 245 / 245 | 100% | 7.01 | 500 / 502 |
| adrenal gland | 100% | 3171.66 | 258 / 258 | 100% | 10.28 | 229 / 230 |
| brain | 99% | 5589.43 | 2605 / 2642 | 100% | 14.39 | 705 / 705 |
| esophagus | 100% | 2864.22 | 1438 / 1445 | 99% | 10.59 | 181 / 183 |
| breast | 100% | 2587.76 | 459 / 459 | 98% | 7.10 | 1098 / 1118 |
| thymus | 100% | 4350.54 | 653 / 653 | 98% | 7.46 | 593 / 605 |
| pancreas | 100% | 2557.22 | 327 / 328 | 98% | 14.46 | 175 / 178 |
| kidney | 100% | 2909.45 | 89 / 89 | 97% | 7.32 | 877 / 901 |
| ovary | 100% | 5801.11 | 180 / 180 | 97% | 7.14 | 415 / 430 |
| bladder | 100% | 3723.95 | 21 / 21 | 96% | 8.04 | 486 / 504 |
| lung | 100% | 3021.17 | 576 / 578 | 97% | 8.46 | 1115 / 1155 |
| skin | 100% | 2809.37 | 1805 / 1809 | 95% | 9.98 | 449 / 472 |
| uterus | 100% | 4717.91 | 170 / 170 | 95% | 7.64 | 435 / 459 |
| stomach | 100% | 2705.61 | 359 / 359 | 93% | 6.23 | 266 / 286 |
| intestine | 100% | 3389.05 | 966 / 966 | 92% | 6.17 | 485 / 527 |
| liver | 100% | 1514.05 | 225 / 226 | 84% | 4.82 | 342 / 406 |
| spleen | 100% | 3780.11 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 4.82 | 1 / 1 |
| blood vessel | 100% | 3570.72 | 1333 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 100% | 2449.35 | 1201 / 1204 | 0% | 0 | 0 / 0 |
| heart | 95% | 2510.65 | 822 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 93% | 4.21 | 42 / 45 |
| muscle | 93% | 1561.65 | 744 / 803 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 83% | 4.85 | 24 / 29 |
| eye | 0% | 0 | 0 / 0 | 65% | 3.43 | 52 / 80 |
| peripheral blood | 44% | 625.43 | 406 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0090263 | Biological process | positive regulation of canonical Wnt signaling pathway |
| GO_0061003 | Biological process | positive regulation of dendritic spine morphogenesis |
| GO_0009950 | Biological process | dorsal/ventral axis specification |
| GO_0050775 | Biological process | positive regulation of dendrite morphogenesis |
| GO_0030154 | Biological process | cell differentiation |
| GO_0017148 | Biological process | negative regulation of translation |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0030308 | Biological process | negative regulation of cell growth |
| GO_0043235 | Cellular component | receptor complex |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005739 | Cellular component | mitochondrion |
| GO_0005813 | Cellular component | centrosome |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005829 | Cellular component | cytosol |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005102 | Molecular function | signaling receptor binding |
| GO_0046872 | Molecular function | metal ion binding |
| GO_0003723 | Molecular function | RNA binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | CAPRIN2 |
| Protein name | Caprin family member 2 Alternative protein CAPRIN2 Caprin-2 (C1q domain-containing protein 1) (Cytoplasmic activation/proliferation-associated protein 2) (Gastric cancer multidrug resistance-associated protein) (Protein EEG-1) (RNA granule protein 140) |
| Synonyms | EEG1 C1QDC1 RNG140 KIAA1873 |
| Description | FUNCTION: Promotes phosphorylation of the Wnt coreceptor LRP6, leading to increased activity of the canonical Wnt signaling pathway . Facilitates constitutive LRP6 phosphorylation by CDK14/CCNY during G2/M stage of the cell cycle, which may potentiate cells for Wnt signaling . May regulate the transport and translation of mRNAs, modulating for instance the expression of proteins involved in synaptic plasticity in neurons (By similarity). Involved in regulation of growth as erythroblasts shift from a highly proliferative state towards their terminal phase of differentiation . May be involved in apoptosis . . |
| Accessions | A0A8I5KUY8 A0A8Q3SHP6 A0A8Q3WKC4 F5H142 A0A8Q3SHW1 ENST00000548676.5 ENST00000687797.1 [Q6IMN6-1] ENST00000692932.1 ENST00000541765.5 ENST00000695369.1 A0A8Q3SHE9 ENST00000695370.1 ENST00000686317.1 ENST00000694880.1 ENST00000695327.1 F5GXI7 ENST00000417045.5 [Q6IMN6-3] ENST00000688163.1 H0YID4 ENST00000695371.1 A0A8Q3WKF3 ENST00000540584.2 A0A8I5KUX4 A0A8Q3WKE6 ENST00000690233.1 ENST00000695402.1 ENST00000695328.1 ENST00000690097.1 H0YGG3 L8E8S3 F5GYA1 A0A8Q3WLH0 H3BM22 A0A8I5KPA6 A0A8I5KRN0 A0A8I5KZC0 F5GZX3 ENST00000695372.1 ENST00000695326.1 ENST00000689016.1 ENST00000695374.1 ENST00000537108.5 ENST00000684863.1 [Q6IMN6-4] ENST00000433722.6 ENST00000543380.5 ENST00000298892.9 [Q6IMN6-2] ENST00000537553.5 A0A8Q3SHV1 ENST00000690126.1 ENST00000540436.6 ENST00000695329.1 A0A8I5KSM9 F5H5J8 ENST00000695398.1 ENST00000542550.6 A0A8Q3SHS5 ENST00000695330.1 ENST00000395805.6 [Q6IMN6-10] ENST00000695400.1 A0A8Q3WKE7 ENST00000454014.6 [Q6IMN6-5] ENST00000695373.1 Q6IMN6 |
